glp-1 company MEDVi is showing what a new kind of can look like A telehealth platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B Beyond the Scale: The Economic

January 2026: New or Expanded Approvals for: GLP-1 Weight Loss, Birth Control Implant, Lung Disease, Menkes, Gaucher

The Type 2 diabetes Some research, such as this 2020 study, has investigated the effects of L-carnitine supplementation on people with type 2 diabetes

GLP1R agonists have been shown to delay the decline of estimated glomerular filtration rate in patients with T2DM, including those with or without moderate-to-severe chronic kidney disease

The logic here is that the underlying pathology is not resolving as cleanly as an acute mechanical injury, and ongoing mucosal protection may require sustained peptide signaling

Without resistance training, your body treats muscle tissue as expendable during a caloric deficit, breaking it down for amino acids and energy while preserving fat stores, because from an evolutionary perspective, fat is more calorically dense and therefore more valuable during a famine